Navigation Links
Fake Drugs Entering the U.S.: Lawyers at Console & Hollawell Highlight Federal Warnings About Counterfeit Medications
Date:12/28/2012

Marlton, NJ (PRWEB) December 28, 2012

Federal regulators are warning more than 350 doctors and medical practices across the country that the Botox they received from a supplier in Canada does not carry federal approval and is most likely counterfeit. The reportedly fake anti-wrinkle drug, shipped by a company owned by Canada Drugs, does not have the approval of the U.S. Food and Drug Administration (FDA) and therefore the agency can’t guarantee its effectiveness or its safety, according to NBC News. The report is the fifth of its kind in 2012 where the FDA issued a warning about drug manufacturers operating outside the country. In New Jersey, injury attorney Richard P. Console Jr. stresses the need for medical professionals to heed these warnings and avoid administering dangerous drugs to patients.

“Healthcare professionals and hospitals have a duty to use approved medications when treating patients,” he said. “Knowingly using a counterfeit drug or failing to inspect medication properly, puts patients at risk for additional injuries and could lead to malpractice actions down the road. Certainly, Botox is no compound to mess around with if you’re not absolutely sure it’s safe.”

The FDA reportedly commented that Canada Drugs has been at the center of shipping of other unapproved or counterfeit medications in 2012. In February, the FDA targeted shipments of the cancer drug Avastin made by Canada Drugs when it warned 19 healthcare providers in the United States of possible counterfeiting. The federal regulator also ordered the shutdown of 4,100 websites later in the year for selling unapproved medications to consumers in the United States, according to published reports. Many of those sites were reportedly operated by agents of Canada Drugs, says NBC News.

Counterfeit drugs may contain dangerous substances that alter the potency of medications, which can lead to higher-strength or ineffective doses. Console, whose firm of medical malpractice attorneys has been helping accident victims obtain compensation since 1994, has seen the dangers of prescription pharmaceuticals in the injuries his clients have suffered.

“Prescription pharmaceuticals are dangerous enough without attempting to use counterfeit copies of approved medications,” he said. “Doctors who try to get away with administering fake or unapproved medications to patients need to be held accountable. The FDA needs to pursue companies that try to make these products available in the United States aggressively, and it appears they’re being proactive. Multiple warnings issued against the same company in a single year would leave me to believe there’s more that could be done to stop the behavior.”

Console & Hollawell P.C. is a personal injury law firm helping victims of medical malpractice in New Jersey. The firm’s attorneys have secured more than $30,000,000 in deserved compensation for their clients, including those affected by deadly prescription drugs.

http://vitals.nbcnews.com/_news/2012/12/24/16128177-fda-warns-doctors-of-counterfeit-botox?lite

Read the full story at http://www.prweb.com/releases/2012/12/prweb10275263.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pharmacy Robots Linked to Bacterial Contamination of Drugs
2. Penn study cautions use of drugs to block niacin flush
3. Urinary Incontinence Drugs May Be More Trouble Than Theyre Worth
4. Discovery could help to develop drugs for organ transplant and cancer patients
5. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
6. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
7. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
8. Seniors Stop Taking Heart Drugs In Medicare Donut Hole
9. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
10. About 1 baby born each hour addicted to opiate drugs in U.S., U-M study shows
11. Blood pressure drugs linked with lower PTSD symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... in state legislatures and Congress to protect parental rights and civil liberties, and ... safety in America. , The demonstration coincides with a press conference taking place ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of the ... Wentz talked about journey and research recently on a blog and discussed some major ... solution to deal with thyroid disease. , Dr. Wentz completed her graduation from ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... services, is proud to announce it has joined the National Association for Home ... interests of chronically ill, disabled, and dying Americans of all ages and the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, ... the launch of a free, public-facing tool for analyzing the costs of various ... to provide comparative information to patients, providers, insurers and pharmaceutical companies about the ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... that the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control ... , The program, developed in association with efforts by the American College of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Taiwan , March 28, 2017  Medeon ... medical device company, is pleased to announce that ... A investment of Panther Orthopedics, Inc., a ... innovative dynamic fixation solutions for orthopedic extremity applications.  ... continues to expand rapidly, primarily due to procedure ...
(Date:3/28/2017)... , March 28, 2017  Rosen Law Firm, a ... a class action lawsuit on behalf of purchasers of ... ) pursuant and/or traceable to Kitov,s initial public offering ... on the open market from November 20, 2015 through ... The lawsuit seeks to recover damages for Kitov investors ...
(Date:3/28/2017)... , March 28, 2017 ... Pharmaceutical Marketing Strategies: Digital as a Key Component ... the changing pharmaceutical marketing landscape in the digital ... new technologies to provide medical advancements, it has ... marketing efforts, mostly relying on traditional channels and ...
Breaking Medicine Technology: